Ca2+ sensitization due to myosin light chain phosphatase inhibition and cytoskeletal reorganization in the myogenic response of skeletal muscle resistance arteries

Journal of Physiology

Volumn 591, Issue 5, 2013, Pages 1235-1250

  Moreno Domínguez, Alejandro ^a   Colinas, Olaia ^a   El Yazbi, Ahmed ^a   Walsh, Emma J ^a   Hill, Michael A ^b   Walsh, Michael P ^a   Cole, William C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CALCIUM ION; CONTRACTILE PROTEIN; G ACTIN; ISOPROTEIN; MYOSIN; MYOSIN LIGHT CHAIN PHOSPHATASE; PROTEIN KINASE C; RHO KINASE; MUSCLE PROTEIN; MYOSIN LIGHT CHAIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; PPP1R12A PROTEIN, RAT; PPP1R14A PROTEIN, RAT; PROTEIN KINASE INHIBITOR;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY MUSCLE; ARTERY RESISTANCE; ARTICLE; CALCIUM SENSITIZATION; CELL STRUCTURE; CONTROLLED STUDY; CREMASTER MUSCLE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GRACILIS MUSCLE; MALE; MOLECULAR WEIGHT; MUSCLE FIBER MEMBRANE RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; ANIMAL; ARTERIAL PRESSURE; ARTERY; CALCIUM SIGNALING; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; MECHANOTRANSDUCTION; METABOLISM; PHOSPHORYLATION; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; TIME; VASCULAR RESISTANCE; VASCULARIZATION; VASOCONSTRICTION;

ACTIN CYTOSKELETON; ANIMALS; ARTERIAL PRESSURE; ARTERIES; CALCIUM SIGNALING; MALE; MECHANOTRANSDUCTION, CELLULAR; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN PHOSPHATASE 1; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; TIME FACTORS; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 84874423302     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.243576     Document Type: Article

References (68)

1. Bayliss WM (1902). On the local reactions of the arterial wall to changes of internal pressure. J Physiol 28, 220-231.
2. Bernard O (2007). Lim kinases, regulators of actin dynamics. Int J Biochem Cell Biol 39, 1071-1076.
3. Bidani AK, Griffin KA, Williamson G, Wang X & Loutzenhiser R (2009). Protective importance of the myogenic response in the renal circulation. Hypertension 54, 393-398.
4. Brekke JF, Gokina NI & Osol G (2002). Vascular smooth muscle cell stress as a determinant of cerebral artery myogenic tone. Am J Physiol Heart Circ Physiol 283, H2210-H2216.
5. Cipolla MJ & Osol G (1998). Vascular smooth muscle actin cytoskeleton in cerebral artery forced dilatation. Stroke 29, 1223-1228.
6. Cipolla MJ, Gokina NI & Osol G (2002). Pressure-induced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behavior. FASEB J 16, 72-76.
7. Cole WC & Welsh DG (2011). Role of myosin light chain kinase and myosin light chain phosphatase in the resistance arterial myogenic response to intravascular pressure. Arch Biochem Biophys 510, 160-173.
8. Corteling RL, Brett SE, Yin H, Zheng XL, Walsh MP & Welsh DG (2007). The functional consequence of RhoA knockdown by RNA interference in rat cerebral arteries. Am J Physiol Heart Circ Physiol 293, H440-H447.
9. Coué M, Brenner SL, Spector I & Korn ED (1987). Inhibition of actin polymerization by latrunculin A. FEBS Lett 213, 316-318.
10. D'Angelo G, Davis MJ & Meininger GA (1997). Calcium and mechanotransduction of the myogenic response. Am J Physiol Heart Circ Physiol 273, H175-H182.
11. Davis MJ (1993). Myogenic response gradient in an arteriolar network. Am J Physiol Heart Circ Physiol 264, H2168-H2179.
12. Davis MJ & Hill MA (1999). Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79, 387-423.
13. Dessy C, Matsuda N, Hulvershorn J, Sougnez CL, Sellke FW & Morgan KG (2000). Evidence for involvement of the PKC-alpha isoform in myogenic contractions of the coronary microcirculation. Am J Physiol Heart Circ Physiol 279, H916-H923.
14. 2+ sensitization of contraction in arterial smooth muscle. Circ Res 100, 121-129.
15. Dora KA (2005). Does arterial myogenic tone determine blood flow distribution in vivo Am J Physiol Heart Circ Physiol 289, H1323-H1325.
16. Drummond GB (2009). Reporting ethical matters in the Journal of Physiology: standards and advice. J Physiol 587, 713-719
17. Dubroca C, You D, Levy BI, Loufrani L & Henrion D (2005). Involvement of RhoA/Rho kinase pathway in myogenic tone in the rabbit facial vein. Hypertension 45, 974-979.
18. El-Yazbi AF, Johnson RP, Walsh EJ, Takeya K, Walsh MP & Cole WC (2010). Pressure-dependent contribution of Rho kinase-mediated calcium sensitization in serotonin-evoked vasoconstriction of rat cerebral arteries. J Physiol 588, 1747-1762.
19. Eto M, Ohmori T, Suzuki M, Furuya K & Morita F (1995). A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J Biochem (Tokyo) 118, 1104-1107.
20. Flavahan NA, Bailey SR, Flavahan WA, Mitra S & Flavahan S (2005). Imaging remodeling of the actin cytoskeleton in vascular smooth muscle cells after mechanosensitive arteriolar constriction. Am J Physiol Heart Circ Physiol 288, H660-H669.
21. Fronek K & Zweifach BW (1975). Microvascular pressure distribution in skeletal muscle and the effect of vasodilation. Am J Physiol 228, 791-796.
22. Gerthoffer WT (2005). Actin cytoskeletal dynamics in smooth muscle contraction. Can J Physiol Pharmacol 83, 851-856.
23. 2+ influx in cerebral arteries. Am J Physiol Heart Circ Physiol 282, H1410-H1420.
24. 2+ sensitivity as a key mechanism of PKC-induced constriction in pressurized cerebral arteries. Am J Physiol Heart Circ Physiol 277, H1178-H1188.
25. Gokina NI, Park KM, McElroy-Yaggy K & Osol G (2005). Effects of Rho kinase inhibition on cerebral artery myogenic tone and reactivity. J Appl Physiol 98, 1940-1948.
26. Gunst SJ & Zhang W (2008). Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. Am J Physiol Cell Physiol 295, C576-C587.
27. Hill MA, Falcone JC & Meininger GA (1990). Evidence for protein kinase C involvement in arteriolar myogenic reactivity. Am J Physiol Heart Circ Physiol 259, H1586-H1594.
28. 2+ signaling pathways underlying myogenic reactivity. J Appl Physiol 91, 973-983.
29. Jarajapu YP & Knot HJ (2005). Relative contribution of Rho kinase and protein kinase C to myogenic tone in rat cerebral arteries in hypertension. Am J Physiol Heart Circ Physiol 289, H1917-H1922.
30. Johnson PC (1986). Autoregulation of blood flow. Circ Res 59, 483-495.
31. 2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response. J Physiol 587, 2537-2553.
32. Jones KA, Perkins WJ, Lorenz RR, Prakash YS, Sieck GC & Warner DO (1999). F-actin stabilization increases tension cost during contraction of permeabilized airway smooth muscle in dogs. J Physiol 519, 527-538.
33. 2+ and protein kinase C in developing myogenic contraction in isolated rat small arteries. Am J Physiol Heart Circ Physiol 272, H1165-H1172.
34. Kim HR, Gallant C, Leavis PC, Gunst SJ & Morgan KG (2008). Cytoskeletal remodeling in differentiated vascular smooth muscle is actin isoform dependent and stimulus dependent. Am J Physiol Cell Physiol 295, C768-C778.
35. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A & Kaibuchi K (1996). Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273, 245-248.
36. 2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508, 199-209.
37. + channels. J Physiol 508, 211-221.
38. 2+ signaling. Am J Physiol Heart Circ Physiol 289, H1326-H1334.
39. Lagaud G, Gaudreault N, Moore ED, Van Breemen C & Laher I (2002). Pressure-dependent myogenic constriction of cerebral arteries occurs independently of voltage-dependent activation. Am J Physiol Heart Circ Physiol 283, H2187-H2195.
40. Liu J, Hill MA & Meininger GA (1994). Mechanisms of myogenic enhancement by norepinephrine. Am J Physiol Heart Circ Physiol 266, H440-H446.
41. Luykenaar KD, El-Rahman RA, Walsh MP & Welsh DG (2009). Rho-kinase-mediated suppression of KDR current in cerebral arteries requires an intact actin cytoskeleton. Am J Physiol Heart Circ Physiol 296, H917-H926.
42. Massett MP, Ungvari Z, Csiszar A, Kaley G & Koller A (2002). Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists. Am J Physiol Heart Circ Physiol 283, H2282-H2287.
43. McCarron JG, Osol G & Halpern W (1989). Myogenic responses are independent of the endothelium in rat pressurized posterior cerebral arteries. Blood Vessels 26, 315-319.
44. Meininger GA Zawieja DC, Falcone JC, Hill MA & Davey JP (1991). Calcium measurement in isolated arterioles during myogenic and agonist stimulation. Am J Physiol Heart Circ Physiol 261, H950-959.
45. Nakamura A, Hayashi K, Ozawa Y, Fujiwara K, Okubo K, Kanda T, Wakino S & Saruta T (2003). Vessel- and vasoconstrictor-dependent role of Rho/Rho-kinase in renal microvascular tone. J Vasc Res 40, 244-251.
46. Ohanian V, Gatfield K & Ohanian J (2005). Role of the actin cytoskeleton in G-protein-coupled receptor activation of PYK2 and paxillin in vascular smooth muscle. Hypertension 46, 93-99.
47. Olsen TS, Larsen B, Skriver EB, Herning M, Enevoldsen E & Lassen NA (1981). Focal cerebral hyperemia in acute stroke. Incidence, pathophysiology and clinical significance. Stroke 12, 598-607
48. Osol G, Laher I & Cipolla M (1991). Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 68, 359-367.
49. Osol G, Brekke JF, McElroy-Yaggy K & Gokina NI (2002). Myogenic tone, reactivity, and forced dilatation: a three-phase model of in vitro arterial myogenic behavior. Am J Physiol Heart Circ Physiol 283, H2260-H2267.
50. Sasaki Y, Suzuki M & Hidaka H (2002). The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]homopiperazine as a probing molecule for Rho-kinase-involved pathway. Pharmacol Ther 93, 225-232.
51. Schubert R & Mulvany MJ (1999). The myogenic response: established facts and attractive hypotheses. Clin Sci (Lond) 96, 313-326.
52. Schubert R, Kalentchuk VU & Krien U (2002). Rho kinase inhibition partly weakens myogenic reactivity in rat small arteries by changing calcium sensitivity. Am J Physiol Heart Circ Physiol 283, H2288-H2295.
53. 2+ sensitivity regulation in promoting myogenic vasoconstriction. Cardiovasc Res 77, 8-18.
54. Shaw L, Ahmed S, Austin C & Taggart M (2003). Inhibitors of actin filament polymerisation attenuate force but not global intracellular calcium in isolated pressurised resistance arteries. J Vasc Res 40, 1-10.
55. 2+ to elicit constriction. Stroke 34, 1491-1496.
56. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83, 1325-1358.
57. Sun D, Kaley G & Koller A (1994). Characteristics and origin of myogenic response in isolated gracilis muscle arterioles. Am J Physiol Heart Circ Physiol 266, H1177-1183.
58. Takeya K, Loutzenhiser K, Shiraishi M, Loutzenhiser R & Walsh MP (2008). A highly sensitive technique to measure myosin regulatory light chain phosphorylation: the first quantification in renal arterioles. Am J Physiol Renal Physiol 294, F1487-F1492.
59. Tanaka T, Ohta H, Kanda K, Tanaka T, Hidaka H & Sobue K (1990). Phosphorylation of high-Mr caldesmon by protein kinase-C modulates the regulatory function of this protein on the interaction between actin and myosin. Eur J Biochem 188, 495-500.
60. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamell L, Charon D & Kirilovsky J (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266, 15771-81.
61. VanBavel E, Wesselman JP & Spaan JA (1998). Myogenic activation and calcium sensitivity of cannulated rat mesenteric small arteries. Circ Res 82, 210-220.
62. VanBavel E, Van der Meulen ET & Spaan JA (2001). Role of Rho-associated protein kinase in tone and calcium sensitivity of cannulated rat mesenteric small arteries. Exp Physiol 86, 585-592.
63. Walsh MP, Thornbury K, Cole WC, Sergeant G, Hollywood M & McHale N (2011). Rho-associated kinase plays a role in rabbit urethral smooth muscle contraction, but not via enhanced myosin light chain phosphorylation. Am J Physiol Renal Physiol 300, F73-F85.
64. Wesselman JP, Spaan JA, van der Meulen ET & VanBavel E (2001). Role of protein kinase C in myogenic calcium-contraction coupling of rat cannulated mesenteric small arteries. Clin Exp Pharmacol Physiol 28, 848-855.
65. Winder SJ & Walsh MP (1990). Smooth muscle calponin: inhibition of actomyosin MgATPase and regulation by phosphorylation. J Biol Chem 265, 10148-10155.
66. Yang Y, Murphy TV, Ella SR, Grayson TH, Haddock R, Hwang YT, Braun AP, Peichun G, Korthuis RJ, Davis MJ & Hill MA (2009). Heterogeneity in function of small artery smooth muscle BKCa: involvement of the beta1-subunit. J Physiol 587, 3025-3044.
67. 2+ sensitization in stretch-induced myogenic tone. Cardiovasc Res 53, 431-438.
68. i in myogenic reactivity and arteriolar tone. Am J Physiol Heart Circ Physiol 269, H1590-H1596.